# Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

> **NCT03128866** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 80 (actual)

## Conditions studied

- Pelvic Mass

## Interventions

- **PROCEDURE:** Hemipelvectomy
- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT03128866
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-05-19
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-03-05

## Collaborators

- National Cancer Institute (NCI)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03128866

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03128866, "Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03128866. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*